Trials / Completed
CompletedNCT00348400
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost |
Timeline
- First posted
- 2006-07-04
- Last updated
- 2007-06-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00348400. Inclusion in this directory is not an endorsement.